No price history available.
Key financial summary
Financials in IDR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | IDRm | 1,046,189 | 1,153,102 | 1,045,721 | 1,362,120 | 1,404,132 | 1,410,668 | N/A | N/A |
| Operating profit | IDRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | IDRm | 148,366 | 177,276 | 97,639 | 178,455 | 175,946 | 136,739 | N/A | N/A |
| EPS reported | IDR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | IDR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | IDR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | IDR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | IDRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | IDRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | IDRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | IDR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | IDR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in IDR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
PT Victoria Care Indonesia Tbk, an Indonesian company established in 1988 with its headquarters in Jakarta Barat, specializes in the manufacturing and distribution of beauty and personal hygiene items. The firm's business activities are categorized into three primary divisions. The Personal Care and Antiseptic segment encompasses a broad spectrum of skincare, makeup, and body care products, including lotions, creams, scrubs, soaps, perfumes, and deodorants, alongside various antiseptic formulations such as liquids, gels, soaps, cleaning fluids, and disinfectants. The Hair Care division focuses on products for hair maintenance and styling, offering items like shampoos, masks, colorants, and agents for perming or straightening. A third, "Others," segment diversifies the company's portfolio with offerings like coffee (in both powder and bean forms), souvenirs, and snack foods. The company markets its extensive product range under several well-known brands, including Miranda, Herborist, Victoria, Nuface, CBD, Iria, and Sixsence. Beyond its domestic sales in Indonesia, PT Victoria Care Indonesia Tbk also engages in international trade, exporting its goods to countries such as Japan, China, Malaysia, Brunei Darussalam, and Hong Kong.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
PT Victoria Care Indonesia Tbk (VICI.JK)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
PT Victoria Care Indonesia Tbk, an Indonesian company established in 1988 with its headquarters in Jakarta Barat, specializes in the manufacturing and distribution of beauty and personal hygiene items. The firm's business activities are categorized into three primary divisions. The Personal Care and Antiseptic segment encompasses a broad spectrum of skincare, makeup, and body care products, including lotions, creams, scrubs, soaps, perfumes, and deodorants, alongside various antiseptic formulations such as liquids, gels, soaps, cleaning fluids, and disinfectants. The Hair Care division focuses on products for hair maintenance and styling, offering items like shampoos, masks, colorants, and agents for perming or straightening. A third, "Others," segment diversifies the company's portfolio with offerings like coffee (in both powder and bean forms), souvenirs, and snack foods. The company markets its extensive product range under several well-known brands, including Miranda, Herborist, Victoria, Nuface, CBD, Iria, and Sixsence. Beyond its domestic sales in Indonesia, PT Victoria Care Indonesia Tbk also engages in international trade, exporting its goods to countries such as Japan, China, Malaysia, Brunei Darussalam, and Hong Kong.
